Carbohydrates are fundamental molecules involved in nearly all aspects of lives, such as being involved in formating the genetic and energy materials, supporting the structure of organisms, constituting invasion and host defense systems, and forming antibiotics secondary metabolites. The naturally occurring carbohydrates and their derivatives have been extensively studied as therapeutic agents for the treatment of various diseases. During 2000 to 2021, totally 54 carbohydrate-based drugs which contain carbohydrate moities as the major structural units have been approved as drugs or diagnostic agents. Here we provide a comprehensive review on the chemical structures, activities, and clinical trial results of these carbohydrate-based drugs, which are categorized by their indications into antiviral drugs, antibacterial/antiparasitic drugs, anticancer drugs, antidiabetics drugs, cardiovascular drugs, nervous system drugs, and other agents.
The glycosyl N-phenyltrifluoroacetimidates (PTFAI) have within the last ten years been applied in the synthesis of a wide variety of the oligosaccharides and glycoconjugates. Especially, these donors are found advantageous in glycosidic coupling with ‘arming’ sugar donors, ketose donors, and with less nucleophilic acceptors. A comprehensive review of the PTFAI donors is provided in a hope to reflect from a particular angle the current status and future trend of the glycosylation chemistry.